Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to address multiple aspects of metabolic dysfunction
These drugs arent directly harmful to your kidneys, but they can sometimes lead to dehydration
Metabolism varies by individual, affecting how quickly peptides clear the system
However, a false positive skin test result is possible given the limitations of skin testing with subcutaneous agents
About 68% of those who stuck with their treatment wound up with normal blood sugar levels, compared with 41% who stopped taking the drugs later in the study and 33% who stopped earlier
The TRANSCEND-T2D-1 trial (NCT06354660) demonstrated HbA1c reductions of 1.7-2.0% and 36.6 lbs mean weight loss in type 2 diabetes participants over 40 weeks
US$ 20.44
US$ 22.66
US$ 28.70
US$ 26.03
US$ 26.96
US$ 26.42
US$ 27.03
US$ 29.46
US$ 27.30
US$ 23.01
US$ 25.17
US$ 24.94
US$ 21.86
